跳至主要内容
临床试验/IRCT201312203449N13
IRCT201312203449N13已完成2 期

Comparing cyproheptadine and placebo efficacy in prevention of delirium incidence in patients hospitalized in intensive care unit

Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria: Non-cardiac surgical patients who are admitted to ICU and are hospitalized in Intensive Care Unit (ICU) for at-least 7 days.

排除标准

  • Patients with history of neurological diseases, psychiatric disorders, cyproheptadine hypersensitivity, active GI bleeding, glaucoma, urinary retention and arrhythmia will be excluded from the study.

研究者

发起方
Vice Chancellor for Research, Tehran University of Medical Sciences

相似试验